154 related articles for article (PubMed ID: 7198460)
1. Toxicological studies of plafibride. Part 3: Study of teratogenic activity in rats and rabbits.
Sanfeliu C; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1831-4. PubMed ID: 7198460
[TBL] [Abstract][Full Text] [Related]
2. Toxicological studies of plafibride. Part 2: Subacute and subchronic toxicity in rats and chronic toxicity in dogs.
Zapatero J; Sanfeliu C; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1819-30. PubMed ID: 7198459
[TBL] [Abstract][Full Text] [Related]
3. Toxicological studies of plafibride. Part 1: Acute toxicity and its determination after several administrations of plafibride.
Zapatero J; Sanfeliu C; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1816-9. PubMed ID: 7198458
[TBL] [Abstract][Full Text] [Related]
4. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
Bruseghini L; Vilageliu J; Freixes J
Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
[TBL] [Abstract][Full Text] [Related]
5. Activity of plafibride on erythrocyte deformability.
Vilageliu J; Freixes J; Bruseghini L
Arzneimittelforschung; 1983; 33(3):401-4. PubMed ID: 6683514
[TBL] [Abstract][Full Text] [Related]
6. Toxicological studies of plafibride. Part 4: Interaction of plafibride with other drugs.
Zapatero J; Basi N; Vilageliu J; Sanfeliu C; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1835-8. PubMed ID: 7198461
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic approach of plafibride in rat.
Zapatero D; Vilageliu J; Torres A; Ribalta JM; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1800-4. PubMed ID: 7198457
[TBL] [Abstract][Full Text] [Related]
8. Plafibride tolerance trial at increasing doses in healthy volunteers.
Dalmau J; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1840-4. PubMed ID: 7198462
[TBL] [Abstract][Full Text] [Related]
9. Hypolipemic activity of plafibride.
Bruseghini L; Vilageliu J; Bagaria A
Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of plafibride in healthy volunteers.
Santaniello E; Conti F; Vilageliu J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1850-2. PubMed ID: 7198464
[TBL] [Abstract][Full Text] [Related]
11. Plafibride tolerance trial in healthy volunteers.
Dalmau J; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1845-9. PubMed ID: 7198463
[TBL] [Abstract][Full Text] [Related]
12. Bacterial mutation test on plafibride.
Richold M; Jones E
Arzneimittelforschung; 1981; 31(10a):1838-40. PubMed ID: 7032531
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials of plafibride in geriatric patients.
Demichelis Genesio MA; Bracons R; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1852-5. PubMed ID: 7198465
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activities and side effects of plafibride.
Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
[TBL] [Abstract][Full Text] [Related]
16. Teratogenicity of the antiallergic Sm 857 SE in rats versus rabbits.
Nishimura M; Kast A; Tsunenari Y; Kobayashi S
Teratology; 1988 Oct; 38(4):351-67. PubMed ID: 2907188
[TBL] [Abstract][Full Text] [Related]
17. Influence of plafibride, an antiplatelet and hypolipemic agent, on prostacyclin and thromboxane synthesis, 3',5'-cyclic AMP phosphodiesterase activity and serum clearance of a lipid emulsion.
Vilageliu J; Freixes J; Giráldez A; Bermejo P; Basi N; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1805-7. PubMed ID: 6274363
[TBL] [Abstract][Full Text] [Related]
18. Plafibride: clinical trial of a new platelet antiaggregating agent.
Olivella J; Vicens B
Arzneimittelforschung; 1981; 31(10a):1856-8. PubMed ID: 7032532
[TBL] [Abstract][Full Text] [Related]
19. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
20. Reproductive toxicity studies of benzalazine in rats and rabbits.
Herzog R; Leuschner J
Arzneimittelforschung; 1994 Dec; 44(12):1368-70. PubMed ID: 7848360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
